Yariş E, Tuncer M, Kayaalp S O, Ilhan M
Department of Pharmacology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Arch Int Pharmacodyn Ther. 1994 Mar-Apr;327(2):166-74.
cyclosporin A is a widely used immunosuppressant agent which has direct vascular effects such as contraction of the arterial smooth muscle and potentiation of other vasoconstrictor agents. In rabbit isolated arterial segments, the contractile effects of a cyclosporin A preparation (Sandimmun; 10(-6) M) and its solvent (Cremophor-EL) were investigated. Both caused an increase in the basal tension of arterial segments after an incubation period of 1 hour. Several substances were tested to antagonize the contractile activity of the cyclosporin A preparation and its solvent. Prednisolone and quinacrine (phospholipase A2 inhibitors), indomethacin (cyclooxygenase inhibitor), verapamil (calcium antagonist), phentolamine (alpha-adrenoceptor blocker), captopril (angiotensin-converting enzyme inhibitor) and prazosin (alpha 1-adrenoceptor-blocking agent) decreased the contractile responses to the cyclosporin A preparation and its solvent in a comparable manner. These findings indicate that the solvent of the cyclosporin A preparation is responsible for the contractile effect of this latter preparation and that this contractile activity cannot be explained by a single mechanism.
环孢素A是一种广泛应用的免疫抑制剂,具有直接的血管效应,如动脉平滑肌收缩以及增强其他血管收缩剂的作用。在兔离体动脉段中,研究了环孢素A制剂(山地明;10⁻⁶M)及其溶剂(聚氧乙烯蓖麻油)的收缩效应。孵育1小时后,二者均导致动脉段基础张力增加。测试了几种物质以拮抗环孢素A制剂及其溶剂的收缩活性。泼尼松龙和奎纳克林(磷脂酶A2抑制剂)、吲哚美辛(环氧化酶抑制剂)、维拉帕米(钙拮抗剂)、酚妥拉明(α-肾上腺素能受体阻滞剂)、卡托普利(血管紧张素转换酶抑制剂)和哌唑嗪(α1-肾上腺素能受体阻滞剂)以类似方式降低了对环孢素A制剂及其溶剂的收缩反应。这些发现表明,环孢素A制剂的溶剂是该制剂收缩效应的原因,且这种收缩活性不能用单一机制来解释。